A Comprehensive Study Employing Computational Analysis and Mendelian Randomization Has Revealed the Impact of Key Genes on Liver Cancer
Open Access
- 27 May 2025
- journal article
- research article
- Published by MDPI AG in Biomedicines
- Vol. 13 (6) , 1313
Abstract
Background and Aims: In this research, we sought to enhance our comprehension of liver cancer’s genetic architecture by employing Mendelian randomization (MR) techniques to establish causative relationships between particular genetic variations and liver cancer susceptibility. Methods: We integrated data from the public databases with MR analysis to identify differentially expressed genes (DEGs) associated with Hepatocellular Carcinoma (HCC). We conducted functional enrichment analyses to determine the biological processes and signaling cascades associated with the identified DEGs. We also used the CIBERSORT deconvolution method to evaluate immune cell composition in HCC tissues, followed by correlation studies examining relationships between our key genes of interest and various immune cell populations. Additionally, we validated our findings using a rat model of HCC and clinical HCC samples. Results: We obtained two key genes, EHD4 and PPARGC1A, which co-regulated M0 macrophages, suggesting their role in macrophage polarization and tumor progression. In addition, PPARGC1A is associated with resting and activated mast cells, suggesting its involvement in regulating the tumor microenvironment. Detection of rat and clinical samples further confirmed the upregulation of these genes in HCC, supporting their potential as therapeutic targets. Conclusions: Our findings emphasize the significant involvement of EHD4 and PPARGC1A in HCC, specifically regarding their influence on tumor-associated macrophage polarization and broader immune microenvironment modulation. These findings offer new insights into the molecular mechanisms driving HCC and suggest that targeting these genes may provide novel strategies for personalized treatment.Keywords
Funding Information
- National Natural Science Foundation of China (82405314, 3502Z202374112)
- Science and Technology Plan Project of Xiamen Municipal Government (82405314, 3502Z202374112)
This publication has 46 references indexed in Scilit:
- Cancer incidence and mortality in China, 2022Journal of the National Cancer Center, 2024
- PPARγ signaling in hepatocarcinogenesis: Mechanistic insights for cellular reprogramming and therapeutic implicationsPharmacology & Therapeutics, 2022
- Global burden of primary liver cancer in 2020 and predictions to 2040Journal of Hepatology, 2022
- The PGC1α/NRF1-MPC1 axis suppresses tumor progression and enhances the sensitivity to sorafenib/doxorubicin treatment in hepatocellular carcinomaFree Radical Biology and Medicine, 2021
- Searching for prognostic biomarkers for small renal masses in the urinary proteomeInternational Journal of Cancer, 2019
- Treatment and outcomes of recurrent hepatocellular carcinomasLangenbeck's Archives of Surgery, 2017
- Genetic profiling of hepatocellular carcinoma using next-generation sequencingJournal of Hepatology, 2016
- Decreased Expression of EHD2 Promotes Tumor Metastasis and Indicates Poor Prognosis in Hepatocellular CarcinomaDigestive Diseases and Sciences, 2016
- Familial Risk and Heritability of Cancer Among Twins in Nordic CountriesJAMA, 2016
- The DEN and CCl4‐Induced Mouse Model of Fibrosis and Inflammation‐Associated Hepatocellular CarcinomaCurrent Protocols in Pharmacology, 2014